Prof Robin Mackenzie - Psychedelic Enhancement of The Dying Process

Psychedelic substances possess potential for enhancing the dying process and addressing end of life distress. Research into these applications requires prioritizing safety and quality of experience, particularly because the subjective nature of the dying process remains poorly understood and can be challenging to manage. Advancements in neuroimaging may offer valuable tools for mapping brain activity during transitional states, thereby helping to inform ethical approaches to end of life care. Integrating compassionate, structured support into the dying experience is important given that current medical protocols often focus on symptom reduction, which can inadvertently pathologize necessary emotional processing. Open communication and rituals involving families can foster a more meaningful, healthy, and supported transition for individuals facing terminal illnesses.